Establishing breakpoints for amoxicillin/clavulanate and ampicillin/sulbactam for rapid antimicrobial susceptibility testing directly from positive blood culture bottles
Journal of Medical Microbiology · 2023
DOI: 10.1099/jmm.0.001672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2023. Verfasst von Elisabeth König und 8 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostic & Research Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Neue Stiftingtalstraße 6, 8010 Graz,…. Hauptthemen laut MEDLINE: Sulbactam, Anti-Infective Agents. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Introduction
In 2018, EUCAST released guidelines on rapid antimicrobial susceptibility testing (RAST) directly from positive blood culture bottles for selected bacterial species and antimicrobial agents, but not for the commonly used agents amoxicillin/clavulanate (AMC) and ampicillin/sulbactam (SAM). Hypothesis/Gap statement . This work addresses the Enterobacterales RAST capability gap for betalactam/betalactamase inhibitor combinations.
Aim
We aimed to determine RAST breakpoints for AMC and SAM for Escherichia coli and Klebsiella pneumoniae after 4 and 6 h of incubation directly from positive blood cultures. Methodology. Blood culture bottles were spiked with clinical isolates of E. coli ( n =89) and K. pneumoniae ( n =81). RAST was performed according to EUCAST guidelines and zones were read after 4 and 6 h. Breakpoints were defined to avoid very major errors.
Results
The proportion of readable zone diameters after 4 h of incubation were 90.8 % in E. coli and 85.8 % in K. pneumoniae isolates. After 6 h of incubation all zone diameters could be read. The proposed breakpoints for E. coli after 6 h of incubation were ≥16 mm S (susceptible), 14–15 mm ATU (area of technical uncertainty) and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diagnostic & Research Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Neue Stiftingtalstraße 6, 8010 Graz, Austria.
- Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
- Institute of Statistics, Graz University of Technology, Kopernikusgasse 24, 8010 Graz, Austria.
Zitieren
APA
König, E., Iser, J., Zechner-Sammer, T., Friedl, H., Krause, R., Valentin, T., Leitner, E., Steinmetz, I., & Zollner-Schwetz, I. (2023). Establishing breakpoints for amoxicillin/clavulanate and ampicillin/sulbactam for rapid antimicrobial susceptibility testing directly from positive blood culture bottles. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.001672
Vancouver
König E, Iser J, Zechner-Sammer T, Friedl H, Krause R, Valentin T, et al. Establishing breakpoints for amoxicillin/clavulanate and ampicillin/sulbactam for rapid antimicrobial susceptibility testing directly from positive blood culture bottles. Journal of Medical Microbiology. 2023. doi:10.1099/jmm.0.001672
BibTeX
@article{Knig2023,
author = {König, Elisabeth and Iser, Juliane and Zechner-Sammer, Tanja and Friedl, Herwig and Krause, Robert and Valentin, Thomas and Leitner, Eva and Steinmetz, Ivo and Zollner-Schwetz, Ines},
title = {Establishing breakpoints for amoxicillin/clavulanate and ampicillin/sulbactam for rapid antimicrobial susceptibility testing directly from positive blood culture bottles},
journal = {Journal of Medical Microbiology},
year = {2023},
doi = {10.1099/jmm.0.001672}
}
EUVIMED